# Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies

> **NCT06387979** · — · SUSPENDED · sponsor: **Mayo Clinic** · enrollment: 285 (estimated)

## Conditions studied

- Glioma

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06387979
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-10-26
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-10-15
- **Target enrollment:** 285 (ESTIMATED)
- **Why stopped:** Funding issues
- **Last updated:** 2025-12-26

## Collaborators

- National Cancer Institute (NCI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387979, "Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT06387979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*